Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient |
Description | STEP INTO A WORLD OF ELEVATED FACTOR IX LEVELS THAT LAST FOR HEMGENIX is the first and only FDA-approved gene therapy for hemophilia B. It is a one-time infusion that offers elevated factor IX levels for |
Keywords | N/A |
WebSite | hemevolution.com |
Host IP | 12.3.33.225 |
Location | United States |
Site | Rank |
US$1,029,009
Last updated: 2023-05-18 14:00:33
hemevolution.com has Semrush global rank of 10,285,924. hemevolution.com has an estimated worth of US$ 1,029,009, based on its estimated Ads revenue. hemevolution.com receives approximately 118,732 unique visitors each day. Its web server is located in United States, with IP address 12.3.33.225. According to SiteAdvisor, hemevolution.com is safe to visit. |
Purchase/Sale Value | US$1,029,009 |
Daily Ads Revenue | US$950 |
Monthly Ads Revenue | US$28,496 |
Yearly Ads Revenue | US$341,948 |
Daily Unique Visitors | 7,916 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hemevolution.com. | A | 7198 | IP: 12.3.33.225 |
hemevolution.com. | NS | 21600 | NS Record: dmtu.mt.ns.els-gms.att.net. |
hemevolution.com. | NS | 21600 | NS Record: dbru.br.ns.els-gms.att.net. |
hemevolution.com. | TXT | 21600 | TXT Record: w5ff2bf97ftrfqwmdgpjs9kc9ynmp0vw |
You are now leaving the current website. The site you are accessing is maintained by a third party over whom CSL Behring has no control. CSL Behring does not review, approve, or necessarily endorse viewpoints, inferences, or conclusions stated in or implied by the content of this site. CSL Behring is not responsible for third-party content or the consequences of your use thereof. Do you want to continue? No Yes X Prescribing Information Important Safety Information For Healthcare Professionals Why Gene Therapy About HEMGENIX Results With HEMGENIX Safety How HEMGENIX Works Steps to Treatment Patient Support Patient Services Resources and FAQs For Healthcare Professionals Facebook Instagram Stay informed David Factor IX level of 37% at 2 years Patient portrayal; HEMGENIX not intended for women HEMGENIX: The first and only FDA-approved gene therapy for hemophilia B STEP INTO A WORLD OF ELEVATED FACTOR IX LEVELS THAT LAST FOR YEARS A one-time infusion delivers greater bleed protection* |
HTTP/1.1 301 Moved permanently Location: https://hemevolution.com/ Connection: close Cache-Control: no-cache Pragma: no-cache HTTP/1.1 301 Moved Permanently Content-Length: 239 Content-Type: text/html Location: https://www.hemevolution.com/ Server: Microsoft-IIS/8.5 X-Powered-By: ASP.NET CSL-Asset: W42 X-Frame-Options: SAMEORIGIN Date: Thu, 23 Jun 2022 09:19:16 GMT Strict-Transport-Security: max-age=157680000 HTTP/1.1 200 OK Cache-Control: private Content-Length: 23634 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/8.5 X-AspNetMvc-Version: 5.2 X-AspNet-Version: 4.0.30319 Set-Cookie: visitor_type=PATIENT; path=/ X-Powered-By: ASP.NET CSL-Asset: W43 X-Frame-Options: SAMEORIGIN Date: Thu, 23 Jun 2022 09:19:17 GMT Strict-Transport-Security: max-age=157680000 Set-Cookie: NSC_mcwt_xxx.IfnFwpmvujpo.dpn=ffffffffaf1c1fb045525d5f4f58455e445a4a423660;Version=1;path=/;secure;httponly |
Domain Name: HEMEVOLUTION.COM Registry Domain ID: 2650198678_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-10-25T18:06:02Z Creation Date: 2021-10-25T18:06:01Z Registry Expiry Date: 2023-10-25T18:06:01Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2086851750 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DBRU.BR.NS.ELS-GMS.ATT.NET Name Server: DMTU.MT.NS.ELS-GMS.ATT.NET DNSSEC: unsigned >>> Last update of whois database: 2022-06-23T09:25:44Z <<< |